| UniProt ID | CHTOP_HUMAN | |
|---|---|---|
| UniProt AC | Q9Y3Y2 | |
| Protein Name | Chromatin target of PRMT1 protein | |
| Gene Name | CHTOP | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 248 | |
| Subcellular Localization | Nucleus . Nucleus, nucleolus . Nucleus, nucleoplasm . Nucleus speckle . Mostly associated with facultative heterochromatin (By similarity). Localizes to regions surrounding nuclear speckles known as perispeckles in which TREX complex assembly seems t | |
| Protein Description | Plays an important role in the ligand-dependent activation of estrogen receptor target genes. [PubMed: 19858291 May play a role in the silencing of fetal globin genes] | |
| Protein Sequence | MAAQSAPKVVLKSTTKMSLNERFTNMLKNKQPTPVNIRASMQQQQQLASARNRRLAQQMENRPSVQAALKLKQSLKQRLGKSNIQARLGRPIGALARGAIGGRGLPIIQRGLPRGGLRGGRATRTLLRGGMSLRGQNLLRGGRAVAPRMGLRRGGVRGRGGPGRGGLGRGAMGRGGIGGRGRGMIGRGRGGFGGRGRGRGRGRGALARPVLTKEQLDNQLDAYMSKTKGHLDAELDAYMAQTDPETND | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 2 | Acetylation | ------MAAQSAPKV ------CCCCCCCEE | 17.76 | 22814378 | |
| 8 | Acetylation | MAAQSAPKVVLKSTT CCCCCCCEEEEECCC | 44.70 | 27452117 | |
| 8 | Ubiquitination | MAAQSAPKVVLKSTT CCCCCCCEEEEECCC | 44.70 | - | |
| 8 (in isoform 3) | Ubiquitination | - | 44.70 | - | |
| 12 | Acetylation | SAPKVVLKSTTKMSL CCCEEEEECCCCCCH | 33.86 | 25953088 | |
| 12 | Ubiquitination | SAPKVVLKSTTKMSL CCCEEEEECCCCCCH | 33.86 | - | |
| 16 | Acetylation | VVLKSTTKMSLNERF EEEECCCCCCHHHHH | 26.95 | 25953088 | |
| 16 (in isoform 3) | Ubiquitination | - | 26.95 | - | |
| 16 | Ubiquitination | VVLKSTTKMSLNERF EEEECCCCCCHHHHH | 26.95 | - | |
| 28 (in isoform 3) | Ubiquitination | - | 51.86 | - | |
| 28 | Ubiquitination | ERFTNMLKNKQPTPV HHHHHHHHCCCCCCC | 51.86 | - | |
| 30 | Malonylation | FTNMLKNKQPTPVNI HHHHHHCCCCCCCCH | 56.94 | 26320211 | |
| 30 (in isoform 3) | Ubiquitination | - | 56.94 | - | |
| 30 | Ubiquitination | FTNMLKNKQPTPVNI HHHHHHCCCCCCCCH | 56.94 | - | |
| 30 | Acetylation | FTNMLKNKQPTPVNI HHHHHHCCCCCCCCH | 56.94 | 30587311 | |
| 33 (in isoform 3) | Phosphorylation | - | 37.06 | 24719451 | |
| 33 | Phosphorylation | MLKNKQPTPVNIRAS HHHCCCCCCCCHHHH | 37.06 | 29255136 | |
| 40 (in isoform 3) | Phosphorylation | - | 13.79 | 27251275 | |
| 40 | Phosphorylation | TPVNIRASMQQQQQL CCCCHHHHHHHHHHH | 13.79 | 21082442 | |
| 41 | Sulfoxidation | PVNIRASMQQQQQLA CCCHHHHHHHHHHHH | 3.99 | 21406390 | |
| 49 | Phosphorylation | QQQQQLASARNRRLA HHHHHHHHHHHHHHH | 36.03 | 21712546 | |
| 59 | Sulfoxidation | NRRLAQQMENRPSVQ HHHHHHHHHCCHHHH | 3.07 | 21406390 | |
| 64 | Phosphorylation | QQMENRPSVQAALKL HHHHCCHHHHHHHHH | 24.51 | 29978859 | |
| 70 | Ubiquitination | PSVQAALKLKQSLKQ HHHHHHHHHHHHHHH | 49.24 | - | |
| 70 (in isoform 3) | Ubiquitination | - | 49.24 | - | |
| 70 | Acetylation | PSVQAALKLKQSLKQ HHHHHHHHHHHHHHH | 49.24 | 25953088 | |
| 70 | Sumoylation | PSVQAALKLKQSLKQ HHHHHHHHHHHHHHH | 49.24 | 28112733 | |
| 72 (in isoform 3) | Ubiquitination | - | 35.93 | - | |
| 81 | Ubiquitination | SLKQRLGKSNIQARL HHHHHHCCCCHHHHH | 44.94 | - | |
| 82 (in isoform 3) | Ubiquitination | - | 37.05 | - | |
| 97 | Dimethylation | RPIGALARGAIGGRG CCHHHHHHHCCCCCC | 35.61 | - | |
| 97 | Methylation | RPIGALARGAIGGRG CCHHHHHHHCCCCCC | 35.61 | - | |
| 103 | Methylation | ARGAIGGRGLPIIQR HHHCCCCCCCCCCCC | 37.96 | - | |
| 110 | Methylation | RGLPIIQRGLPRGGL CCCCCCCCCCCCCCC | 37.90 | - | |
| 110 | Dimethylation | RGLPIIQRGLPRGGL CCCCCCCCCCCCCCC | 37.90 | - | |
| 114 | Methylation | IIQRGLPRGGLRGGR CCCCCCCCCCCCCCH | 57.78 | - | |
| 114 | Dimethylation | IIQRGLPRGGLRGGR CCCCCCCCCCCCCCH | 57.78 | - | |
| 118 | Methylation | GLPRGGLRGGRATRT CCCCCCCCCCHHHHH | 49.12 | - | |
| 118 | Dimethylation | GLPRGGLRGGRATRT CCCCCCCCCCHHHHH | 49.12 | - | |
| 121 | Methylation | RGGLRGGRATRTLLR CCCCCCCHHHHHHHH | 35.29 | - | |
| 121 | Dimethylation | RGGLRGGRATRTLLR CCCCCCCHHHHHHHH | 35.29 | - | |
| 128 | Methylation | RATRTLLRGGMSLRG HHHHHHHHCCCCCCC | 42.61 | - | |
| 128 (in isoform 4) | Methylation | - | 42.61 | - | |
| 128 | Dimethylation | RATRTLLRGGMSLRG HHHHHHHHCCCCCCC | 42.61 | - | |
| 134 | Methylation | LRGGMSLRGQNLLRG HHCCCCCCCCCHHCC | 37.03 | - | |
| 134 | Dimethylation | LRGGMSLRGQNLLRG HHCCCCCCCCCHHCC | 37.03 | - | |
| 140 | Dimethylation | LRGQNLLRGGRAVAP CCCCCHHCCCCCCCC | 49.00 | - | |
| 140 | Methylation | LRGQNLLRGGRAVAP CCCCCHHCCCCCCCC | 49.00 | - | |
| 143 | Methylation | QNLLRGGRAVAPRMG CCHHCCCCCCCCCCC | 28.81 | - | |
| 143 | Dimethylation | QNLLRGGRAVAPRMG CCHHCCCCCCCCCCC | 28.81 | - | |
| 148 | Methylation | GGRAVAPRMGLRRGG CCCCCCCCCCCCCCC | 23.28 | - | |
| 148 | Dimethylation | GGRAVAPRMGLRRGG CCCCCCCCCCCCCCC | 23.28 | - | |
| 152 | Methylation | VAPRMGLRRGGVRGR CCCCCCCCCCCCCCC | 29.48 | - | |
| 153 | Dimethylation | APRMGLRRGGVRGRG CCCCCCCCCCCCCCC | 51.78 | - | |
| 153 | Methylation | APRMGLRRGGVRGRG CCCCCCCCCCCCCCC | 51.78 | - | |
| 157 | Methylation | GLRRGGVRGRGGPGR CCCCCCCCCCCCCCC | 32.16 | - | |
| 157 | Dimethylation | GLRRGGVRGRGGPGR CCCCCCCCCCCCCCC | 32.16 | - | |
| 159 | Methylation | RRGGVRGRGGPGRGG CCCCCCCCCCCCCCC | 36.01 | - | |
| 159 | Dimethylation | RRGGVRGRGGPGRGG CCCCCCCCCCCCCCC | 36.01 | - | |
| 164 | Methylation | RGRGGPGRGGLGRGA CCCCCCCCCCCCCCC | 38.86 | - | |
| 164 | Dimethylation | RGRGGPGRGGLGRGA CCCCCCCCCCCCCCC | 38.86 | - | |
| 169 | Methylation | PGRGGLGRGAMGRGG CCCCCCCCCCCCCCC | 34.44 | - | |
| 174 | Methylation | LGRGAMGRGGIGGRG CCCCCCCCCCCCCCC | 27.38 | - | |
| 180 | Ubiquitination | GRGGIGGRGRGMIGR CCCCCCCCCCCCCCC | 26.82 | 21890473 | |
| 180 | Methylation | GRGGIGGRGRGMIGR CCCCCCCCCCCCCCC | 26.82 | - | |
| 182 | Methylation | GGIGGRGRGMIGRGR CCCCCCCCCCCCCCC | 30.10 | - | |
| 187 | Methylation | RGRGMIGRGRGGFGG CCCCCCCCCCCCCCC | 22.25 | - | |
| 189 | Methylation | RGMIGRGRGGFGGRG CCCCCCCCCCCCCCC | 40.47 | - | |
| 203 | Methylation | GRGRGRGRGALARPV CCCCCCCCCCCCCCC | 26.33 | - | |
| 203 | Dimethylation | GRGRGRGRGALARPV CCCCCCCCCCCCCCC | 26.33 | - | |
| 208 | Methylation | RGRGALARPVLTKEQ CCCCCCCCCCCCHHH | 23.78 | - | |
| 212 | Phosphorylation | ALARPVLTKEQLDNQ CCCCCCCCHHHHHHH | 32.54 | 29978859 | |
| 213 | Ubiquitination | LARPVLTKEQLDNQL CCCCCCCHHHHHHHH | 39.02 | - | |
| 214 (in isoform 3) | Ubiquitination | - | 51.66 | - | |
| 223 | Phosphorylation | LDNQLDAYMSKTKGH HHHHHHHHHHHCCCC | 11.11 | 29978859 | |
| 225 | Phosphorylation | NQLDAYMSKTKGHLD HHHHHHHHHCCCCHH | 25.21 | 29978859 | |
| 226 (in isoform 1) | Ubiquitination | - | 37.41 | 21890473 | |
| 226 | Ubiquitination | QLDAYMSKTKGHLDA HHHHHHHHCCCCHHH | 37.41 | 21890473 | |
| 226 | Acetylation | QLDAYMSKTKGHLDA HHHHHHHHCCCCHHH | 37.41 | 23236377 | |
| 227 (in isoform 3) | Ubiquitination | - | 34.64 | 21890473 | |
| 227 | Phosphorylation | LDAYMSKTKGHLDAE HHHHHHHCCCCHHHH | 34.64 | 20068231 | |
| 228 | Ubiquitination | DAYMSKTKGHLDAEL HHHHHHCCCCHHHHH | 48.33 | 2190698 | |
| 228 (in isoform 1) | Ubiquitination | - | 48.33 | 21890473 | |
| 229 (in isoform 3) | Ubiquitination | - | 31.64 | 21890473 | |
| 238 | Phosphorylation | LDAELDAYMAQTDPE HHHHHHHHHHHCCCC | 7.83 | 30266825 | |
| 242 | Phosphorylation | LDAYMAQTDPETND- HHHHHHHCCCCCCC- | 43.94 | 30266825 | |
| 243 (in isoform 3) | Phosphorylation | - | 27.27 | 24719451 | |
| 246 | Phosphorylation | MAQTDPETND----- HHHCCCCCCC----- | 50.50 | 30266825 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
| 212 | T | Phosphorylation | Kinase | CHEK1 | O14757 | GPS |
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of CHTOP_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of CHTOP_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| A4_HUMAN | APP | physical | 21832049 | |
| KHDR2_HUMAN | KHDRBS2 | physical | 25416956 | |
| ANM5_HUMAN | PRMT5 | physical | 25284789 | |
| ANM1_HUMAN | PRMT1 | physical | 25284789 | |
| MEP50_HUMAN | WDR77 | physical | 25284789 | |
| ERH_HUMAN | ERH | physical | 25284789 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "Evaluation of the low-specificity protease elastase for large-scalephosphoproteome analysis."; Wang B., Malik R., Nigg E.A., Korner R.; Anal. Chem. 80:9526-9533(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-33 AND SER-40, AND MASSSPECTROMETRY. | |
| "Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-242, AND MASSSPECTROMETRY. | |